Elpiscience has a robust pipeline of next-generation cancer immunotherapies, including four clinical-stage programs, focused on removing immunosuppressive factors and reinvigorating exhausted T cells in the tumor microenvironment (TME).
Elpiscience Biopharma, Ltd.
Address: Bldg. 3, 998 Halei Rd., Pudong, Shanghai, 201203, P.R. China
Tel: +86 21 50651310
Elpiscience (Suzhou) Biopharma, Ltd.
Address: Bldg. 17, Biobay, 218 Sangtian St., SIP, Jiangsu, 215123, P.R. China
Tel: +86 0512 81887999
Elpiscience Biopharmaceuticals USA, Inc.
Address: 12410 Milestone Center Drive, Suite 600, Germantown, MD, USA 20876
Copyright © 2022 Elpiscience. All Rights Reserved. 沪ICP备18016071号-1